Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03796793 · ClinicalTrials.gov registry record · NA

Developing Strategies for Effective Debridement in Patients for Venous Leg Ulcers

A NA study of Venous Leg Ulcer, sponsored by University of Miami.

Active
Registry status
NA
Development phase
136
Enrollment target
1
Study location

NCT03796793 is a NA study of Venous Leg Ulcer that is active but no longer recruiting, run by University of Miami. The registered enrollment target is 136 participants, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03796793, a NA study of Venous Leg Ulcer, is active but no longer recruiting, sponsored by University of Miami.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
136 participants
Enrollment target
1
Study location

Study Summary

The goal of this project is to use genomic profiling, candidate genes and proteins to develop guided surgical debridement to improve healing in chronic non-healing venous leg ulcers (VLUs) and to test the efficacy of this approach.

Conditions Studied

Interventions

  • OTHER Standard of Care Treatment
  • PROCEDURE Wound Edge Debridement

Study Locations (1)

Florida

  • University of Miami - Miami

Trial Details

FieldValue
Enrollment Target 136 participants
Start Date 2019-03-18
Est. Completion 2025-12-31
Phase NA

Sponsor

University of Miami

721 total trials

What the Registry Record Tells You About NCT03796793

The ClinicalTrials.gov registry entry for NCT03796793 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 136 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 241-participant average among 35 other Venous Leg Ulcer trials with a reported enrollment target (44% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Venous Leg Ulcer appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care Treatment is the first listed.

NCT03796793 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT03796793 about?

NCT03796793 is a clinical study titled "Developing Strategies for Effective Debridement in Patients for Venous Leg Ulcers". The goal of this project is to use genomic profiling, candidate genes and proteins to develop guided surgical debridement to improve healing in chronic non-healing venous leg ulcers (VLUs) and to test the efficacy of this approach.

What is the current status of trial NCT03796793?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 136 participants. The study started on 2019-03-18. Estimated completion is 2025-12-31.

What conditions does trial NCT03796793 study?

This clinical trial studies the following conditions: Venous Leg Ulcer.

What interventions are being tested in trial NCT03796793?

The interventions under investigation include: Standard of Care Treatment (OTHER), Wound Edge Debridement (PROCEDURE).

Who is sponsoring clinical trial NCT03796793?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03796793 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Venous Leg Ulcer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.